Monotreatment | Add-on treatment | Other therapy | Total | |
---|---|---|---|---|
AID | ||||
Enteritis, n (%) | 175 (21.8) | 19 (2.4) | 15 (1.9) | 209 (26.1) |
Enterocolitis, n (%) | 35 (4.4) | 19 (2.4) | 5 (0.6) | 59 (7.4) |
Gastroenteritis, n (%) | 312 (38.9) | 106 (13.2) | 116 (14.5) | 534 (66.6) |
IBD | ||||
Ulcerative colitis, n (%) | 10 (18.9) | 14 (26.4) | 3 (5.7) | 27 (50.9) |
Acute, n (%) | 8 (15.1) | 7 (13.2) | 3 (5.7) | 18 (34.0) |
In remission, n (%) | 2 (3.8) | 7 (13.2) | – | 9 (17.0) |
Crohn's disease, n (%) | 11 (20.8) | 14 (26.4) | 1 (1.9) | 26 (49.1) |
Acute, n (%) | 7 (13.2) | 9 (17.0) | – | 16 (30.2) |
In remission, n (%) | 4 (7.5) | 5 (9.4) | 1 (1.9) | 10 (18.9) |
AID, acute inflammatory disorders; IBD, inflammatory bowel diseases.